QLGN NASDAQ
Qualigen Therapeutics, Inc.
1W: +4.4%
1M: -6.3%
3M: +18.5%
1Y: -39.2%
3Y: -96.8%
5Y: -99.9%
$3.21
Last traded 2025-12-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-25M
Net Income
-264.7% YoY
$-12M
Free Cash Flow
-80.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-1263.9%
ROA-448.1%
ROIC-247.1%
Valuation
P/E-0.5
P/B11.5
EV/EBITDA-2.9
Leverage
Debt/Equity0.01
Current Ratio3.68
Interest Cov.-3.9x
Quality Scores
Piotroski F3/9
Altman Z-12.31
Beneish M0.00